GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 789 filers reported holding GLAXOSMITHKLINE PLC in Q3 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $19,000 | -24.0% | 445 | -33.1% | 0.01% | 0.0% |
Q3 2021 | $25,000 | -3.8% | 665 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $26,000 | +8.3% | 665 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $24,000 | 0.0% | 665 | 0.0% | 0.01% | -10.0% |
Q4 2020 | $24,000 | +9.1% | 665 | +12.5% | 0.01% | -9.1% |
Q3 2020 | $22,000 | -8.3% | 591 | 0.0% | 0.01% | -15.4% |
Q2 2020 | $24,000 | +4.3% | 591 | 0.0% | 0.01% | -55.2% |
Q1 2020 | $23,000 | -28.1% | 591 | -21.8% | 0.03% | +38.1% |
Q3 2019 | $32,000 | +3.2% | 756 | 0.0% | 0.02% | 0.0% |
Q2 2019 | $31,000 | 0.0% | 756 | 0.0% | 0.02% | -4.5% |
Q1 2019 | $31,000 | +6.9% | 756 | 0.0% | 0.02% | -4.3% |
Q4 2018 | $29,000 | -6.5% | 756 | 0.0% | 0.02% | +9.5% |
Q3 2018 | $31,000 | +19.2% | 756 | +17.0% | 0.02% | +10.5% |
Q2 2018 | $26,000 | -60.0% | 646 | -61.2% | 0.02% | -60.4% |
Q1 2018 | $65,000 | – | 1,665 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |